Verdi Oncology is an oncology practice management company founded in 2018 in partnership with Pharos Capital – a physician-founded private equity firm. Pharos Capital is focused on growing healthcare companies that lower the total cost of care, improve patient outcomes and expand access to care.
Headquartered in Brentwood, Tennessee with practice locations across the U.S., we empower oncology practices, physicians, and hospitals to create value through high quality, low cost, patient centric oncology care.
Verdi was founded on the belief that cancer treatment should be patient centric and value based. To this end, we have invested heavily in five core components of our Verdi Excellence program: patient experience, patient growth, clinical pathways, practice efficiency and value-based care.
We will continue to be pioneers in the field of oncological care and, with the help of members of our network, improve cancer treatment for our patients and their families.